[Does Hepavis have value in the therapy of fatty liver caused by alcohol poisoning?].
During the therapy of fatty liver (resp. fatty liver hepatitis) the additional application of Hepavis besides the prohibition of alcohol does not have any advantages in comparison to an additional application of a placebo. So the significant decrease of the fat content of the liver under those circumstances seems to be only the consequence of lacking alcohol consume, but not a specific effect of Hepavis. Consequently the treatment of alcoholtoxic fatty liver can be no other than to avoid alcohol, one of the most important causes of illness nowadays.
Odegaard
S
S
Innere Abteilung I, Städtisches Krankenhaus Bietigheim, Akademisches Lehrkrankenhaus der Universität Heidelberg.
Busch
D
D
D000328:Adult; D002794:Choline / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003685:Dehydrocholic Acid / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations / Q000627:therapeutic use; D005235:Fatty Liver, Alcoholic / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009963:Orotic Acid / Q000627:therapeutic use*; D011897:Random Allocation; D014805:Vitamin B 12 / Q000627:therapeutic use*
D004338:Drug Combinations; D009963:Orotic Acid; C015916:choline, dehydrocholic acid, magnesium orotate, orotic acid, Vitamin B12 drug combination; D002794:Choline; D003685:Dehydrocholic Acid; D014805:Vitamin B 12
Hat Hepavis einen Stellenwert in der Therapie der äthyltoxischen Fettleber?